Skip to main content
. 2024 Feb 13;18:1667. doi: 10.3332/ecancer.2024.1667

Table 2. Sequencing of ALK-TKI.

Crizotinib Ceritinib Alectinib Lorlatinib Chemotherapy*
First line 27 4 0 7
Second line 6 16 2 11 3
Third line 4 0 21 3
Fourth line 1 1 4 2
Later lines _ _ _ 2 2

ALK, anaplastic lymphoma kinase; TKI, tyrosine kinase inhibitor

*

Chemotherapy regimen was platinum based- either with pemetrexed or paclitaxel